Fundraise / allotmentFiled on BSE ·
Mukka Proteins Limited allots 2 crore convertible warrants on preferential basis
What the filing says
- Allotment of 2,00,00,000 convertible warrants at ₹23.50 each, aggregating ₹47 crore, to 15 non-promoter investors on September 9, 2026
- Warrants issued under preferential allotment with upfront 25% payment received; balance to be paid within 18 months for equity shares conversion
- Warrants and resulting equity shares subject to SEBI ICDR Regulations lock-in provisions; investor names and quantities disclosed
Original filing
Announcement under Regulation 30 (LODR)-Allotment
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Mukka Proteins Ltd
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentMIC Electronics LtdEbisu Global Opportunities Fund Limited acquires shares in MIC Electronics Limited
- Fundraise / allotmentBhagyanagar India LtdBhagyanagar India Limited allotment of shares by Tieramet Limited after demerger
- Fundraise / allotmentSuryoday Small Finance Bank LtdSuryoday Small Finance Bank allots ₹200 crore subordinate NCDs on private placement
- Fundraise / allotmentKrsnaa Diagnost.Krsnaa Diagnostics receives corrected in-principle approval from BSE for warrants issue
- Fundraise / allotmentSMC Global Securities LtdSMC Global Securities to discuss Preferential Warrant Issuance on Oct 14, 2026
- Fundraise / allotmentEmbassy Developments LtdEmbassy Developments Limited credit rating upgraded to IVR A/Stable on Oct 9, 2026
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.